Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
CAMA-1
HR+
Luminal
Carboplatin
DNA cross-linker
DNA cross-linker
9210.011
uM
212.54010
365.14720
-0.9298 -1.0000 2.0301 0.2289
0.9851
0.9440
BT-474
HER2amp
Luminal
GSK923295
CENPE
Kinesin
9157.001
uM
5.53880
13.18950
-0.6286 -1.0000 1.2662 0.2774
0.8652
0.9211
21MT-1
HER2amp
-
Mebendazole
13719.174
uM
31.97060
77.55140
0.0875 -1.0000 1.2398 0.1610
0.8782
0.8124
BT-549
TNBC
Basal B
Lestaurtinib
FLT3/JAK2/TrkA
RTK
12305.167
uM
1.61670
6.36660
-0.7128 -1.0000 0.8015 0.3323
0.9667
2.8814
184A1
NM
Basal
Ispinesib
KSP
Kinesin
5894.067
uM
1.62180
3.48940
-0.9288 -1.0000 1.4339 0.3983
0.9581
1.5647
BT-474
HER2amp
Luminal
AS-252424
PI3K
PI3K
12291.165
uM
0.41097
147.3160
-0.1202 -1.0000 0.1868 0.4109
0.6135
0.5602
HCC1395
TNBC
Basal B
Fascaplysin
CDK4
CDK
7435.084
uM
0.27572
0.41327
-0.9997 -1.0000 2.7144 0.7084
0.9961
0.8646
BT-474
HER2amp
Luminal
Sigma A6730
AKT
AKT
12178.158
uM
1.57950
4.28540
-0.8896 -1.0000 1.1007 0.4947
0.9798
0.7379
BT-20
TNBC
Basal A
NSC 663284
CDC25
CDC
10581.14
uM
2.50810
5.45180
-0.9836 -1.0000 1.4150 0.6051
0.9839
0.9569
BT-20
TNBC
Basal A
Z-Leu-Leu-Norvalinal
Proteasome
Proteasome
14230.189
uM
0.27401
0.47494
-1.0000 -1.0000 1.9974 0.7978
0.9974
0.4635
184A1
NM
Basal
Ispinesib
KSP
Kinesin
5895.067
uM
2.25070
4.57410
-0.9091 -1.0000 1.5491 0.3497
0.9692
1.4053
BT-549
TNBC
Basal B
Nelfinavir
12690.174
uM
9.7440
13.750
-0.8879 -1.0000 3.1900 0.1406
0.9994
2.4378
BT-474
HER2amp
Luminal
Vinorelbine
TUBB
TUBB
7798.018
uM
0.07033
1.33570
-0.8933 -1.0000 0.3732 0.6131
0.8869
1.4461
AU565
HER2amp
Luminal
L-779450
BRAF
MAPK
10880.149
uM
41.97630
133.38290
0.5726 -1.0000 0.9503 0.0531
0.9147
1.6289
21MT-1
HER2amp
-
Nelfinavir
13719.174
uM
10.30820
13.49270
-0.9513 -1.0000 4.0808 0.1693
0.9959
0.8124
BT-20
TNBC
Basal A
AS-252424
PI3K
PI3K
11854.158
uM
24.60350
145.14930
0.2089 -1.0000 0.6190 0.1259
0.9644
1.3776
BT-20
TNBC
Basal A
L-779450
BRAF
MAPK
11854.161
uM
34.51650
42.99810
-0.3604 -1.0000 5.0000 0.0676
0.9896
1.2085
AU565
HER2amp
Luminal
Lestaurtinib
FLT3/JAK2/TrkA
RTK
10880.154
uM
1.08830
3.54840
-0.8526 -1.0000 0.9295 0.4164
0.9828
1.7853
184A1
NM
Basal
Ixabepilone
TUBB
TUBB
5895.095
uM
0.14338
0.76637
-0.9501 -1.0000 0.6554 0.6829
0.9483
1.4629
BT-474
HER2amp
Luminal
Sorafenib
PDGFR/VEGFR/KIT/FLT3
RTK
5905.085
uM
25.84930
58.21470
-0.9937 -1.0000 1.3532 0.3254
0.9707
0.8847
BT-483
HR+
Luminal
L-779450
BRAF
MAPK
11855.161
uM
6.06830
274.20550
0.0925 -1.0000 0.2883 0.2708
0.7203
0.5957
AU565
HER2amp
Luminal
Methylglyoxal
13149.184
uM
130.14740
469.55390
-0.9992 -1.0000 0.8562 0.7768
0.9575
0.8650
AU565
HER2amp
Luminal
Methylglyoxal
13030.184
uM
50.30640
183.32630
-1.0000 -1.0000 0.8496 0.9024
0.9717
0.5725
HCC1428
HR+
Luminal
PD173074
FGFR1/3
RTK
10441.093
uM
4.87910
7.92130
-0.9402 -1.0000 2.2671 0.2803
0.9867
1.1458
HCC1428
HR+
Luminal
PD173074
FGFR1/3
RTK
7442.1
uM
8.010
14.52550
-0.9818 -1.0000 1.8457 0.3253
0.9730
0.8780